Candel Therapeutics
NASDAQ:CADL
Candel Therapeutics Inc is a late clinical stage biopharmaceutical company. It is focused on helping patients fight cancer with oncolytic viral immunotherapies.
- NORTH AMERICA EDITIONAustraliaNorth AmericaWorld
Investing News NetworkYour trusted source for investing success
Featured Articles and Interviews
More Featured Articles and Inverviews
Press Releases
More Press Releases
At Candel Therapeutics, our team is developing viral immunotherapies that light up and empower the immune system to fight cancer
Interactive Chart
Investing News Network websites or approved third-party tools use cookies. Please refer to the cookie policy for collected data, privacy and GDPR compliance. By continuing to browse the site, you agree to our use of cookies.Â